The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults. Posted 2023-03-10T17:59:14+00:00 - Updated ...

May 30 (UPI) --Ketamine nasal spray may be effective in treating chronic migraines, according to a new study.Publishing in the open access journal Regional Anesthesia & Pain Medicine, researchers ...

Part of what makes this new migraine nasal spray noteworthy is that it targets migraines in a different way than commonly used migraine medications, such as triptans.Zavegepant is the first nasal ...

The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the open access journal Regional ...

Zavzpret ™ (zavegepant) nasal spray is now available for the acute treatment of migraine with or without aura in adults.. Zavzpret is a calcitonin gene-related peptide (CGRP) receptor antagonist ...

A new nasal spray medication called zavegepant, which aims for near-instant relief from migraine headaches, is expected to hit pharmacies later this month or early July.

Migraines: Earlier this year the Food and Drug Administration approved a new nasal spray treatment for migraines, which can relieve pain in as little as 15 minutes — faster than oral pain-relief ...

Pavlovic and colleagues conducted a phase 2/3, open-label safety study of 10 mg zavegepant nasal spray for treatment of acute migraine in 603 adults (mean age, 42.1 years; 85.7% women).

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg ...

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the open access journal Regional ...

The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults. The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome ...